Finland· FI-REL-REL44971
Menjugate
A meningokokkus c, gereinigtes polysaccharid-antigen, konjugiert product containing neisseria meningitidis c oligosaccharide, diphtheria conjugate, registered in Finland by Glaxosmithkline Vaccines S.r.l.. The same ATC class is registered in 6 of our 19 countries.
Checked against Fimea (Finland) on
Informational only — not a medical device.
Where it is registered
Meningokokkus c, gereinigtes polysaccharid-antigen, konjugiert is registered in 6 of 19 countries.
Countries holding a registration under ATC J07AH07 (meningokokkus c, gereinigtes polysaccharid-antigen, konjugiert), each read from that country’s own register.
- This record: Finland, from Fimea (Finland)
- 4 of them publish a price we can compare per daily dose
Meningokokkus c, gereinigtes polysaccharid-antigen, konjugiert · ATC J07AH07
6 / 19 countries
- Belgiumprice
- Canada
- Finlandprice
- Netherlands
- Polandprice
- Switzerlandprice
The record
At a glance
Fimea (Finland)- Active substance
- Neisseria meningitidis C oligosaccharide, diphtheria conjugate
- Manufacturer
- Glaxosmithkline Vaccines S.r.l.
- Country
- Finland (FI)
- ATC code
- J07AH07
- ATC class
- Meningokokkus C, gereinigtes Polysaccharid-Antigen, konjugiert
- Reimbursed
- Not published by this register
- Source register
- Fimea (Finland)
- Last checked
- September 27, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under J07AH07
Meningokokkus c, gereinigtes polysaccharid-antigen, konjugiert, as other registers publish it.
- BelgiumMeningitec 10 µgNuron Biotech
- FinlandMenjugateNovartis Vaccines and Diagnostics S.r.l.
- FinlandMenjugateGlaxosmithkline Vaccines S.r.l.
- BelgiumMenjugate 10 µgGSK Vaccines
- BelgiumMenjugate 10 µgGSK Vaccines
- FinlandMenjugate KitGlaxosmithkline Vaccines S.r.l.
- FinlandNeisvac-CPfizer Oy
- PolandNeisVac-CPfizer Europe MA EEIG
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Fimea (Finland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/95d07c03-99f2-447e-ba83-68368ccc1aaf GET /v1/drugs/95d07c03-99f2-447e-ba83-68368ccc1aaf?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"ddd": null,
"form": "injektioneste, suspensio, esitäytetty ruisku",
"route": null,
"ddd_unit": null,
"strength": "10 mikrog / 0.5 ml",
"atc_label": "meningokokki C, puhdistettu polysakkaridi antigeeniin konjugoitu",
"ma_number": "32134",
"auth_status": "Myyntilupa peruuntunut",
"eu_ma_number": null,
"fimea_rel_id": "REL44971",
"authorised_at": "2015-08-18"
}See everything about meningokokkus c, gereinigtes polysaccharid-antigen, konjugiert.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.